Tag Archives: University of Athens Medical School

ESMO Virtual Congress 2020: Libtayo positive pivotal data offer hope for the treatment of advanced basal cell carcinoma, a difficult-to-treat cancer

Posted on 18, September 2020 by EuropaWire PR Editors

Libtayo is the first investigational medicine to show a clinical benefit in advanced basal cell carcinoma following treatment with a hedgehog inhibitor in a prospective trial 31% objective response rate seen in trial patients, and an estimated 85% of responses … Read the full press release →

Posted in France, Healthcare, News, Pharma & Biotech, Science

Tagged advanced basal cell carcinoma, Alexander Stratigos M.D., Andreas Sygros Hospital, basal cell carcinoma, BCC, biopharmaceutical, cemiplimab, ESMO Virtual Congress 2020, European Society for Medical Oncology, hedgehog inhibitor, HHI therapy, inhibitor, Libtayo®, Regeneron, Sanofi, University of Athens Medical School